FL regimen: Difference between revisions
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx. ==Regimen== {{chemo|x|xx}} {{chemo|x|xx}}...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{SI}} | {{SI}} | ||
{{CMG}}; {{AE}} {{AV}} | {{CMG}}; {{AE}} {{AV}} | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of | {{PAGENAME}} refers to a regimen consisting of [[fludarabine]] , [[amsacrine]] , and [[ara-c]] used to treat xxx.<ref name="pmid21963618">{{cite journal| author=Saure C, Schroeder T, Zohren F, Groten A, Bruns I, Czibere A et al.| title=Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen. | journal=Biol Blood Marrow Transplant | year= 2012 | volume= 18 | issue= 3 | pages= 466-72 | pmid=21963618 | doi=10.1016/j.bbmt.2011.09.006 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21963618 }} </ref> | ||
==Regimen== | ==Regimen== | ||
{{chemo| | {{chemo|FL|Fludarabine}} | ||
{{chemo| | {{chemo|AMS|Amsacrine}} | ||
{{chemo| | {{chemo|A|Ara-c}} | ||
==Indications== | ==Indications== | ||
Revision as of 20:05, 30 March 2015
|
WikiDoc Resources for FL regimen |
|
Articles |
|---|
|
Most recent articles on FL regimen |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on FL regimen at Clinical Trials.gov Clinical Trials on FL regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on FL regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on FL regimen Discussion groups on FL regimen Patient Handouts on FL regimen Directions to Hospitals Treating FL regimen Risk calculators and risk factors for FL regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for FL regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
FL regimen refers to a regimen consisting of fludarabine , amsacrine , and ara-c used to treat xxx.[1]
Regimen
FLFludarabine
AMSAmsacrine
AAra-c
Indications
References
- ↑ Saure C, Schroeder T, Zohren F, Groten A, Bruns I, Czibere A; et al. (2012). "Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen". Biol Blood Marrow Transplant. 18 (3): 466–72. doi:10.1016/j.bbmt.2011.09.006. PMID 21963618.